These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings

1. Abbott's Q1 sales were $10.36 billion, up 7.2% year on year. 2. Adjusted EPS of $1.09 beat consensus and management guidance. 3. Second quarter EPS outlook is $1.23-$1.27, slightly above consensus. 4. Analysts increased price targets for Abbott following earnings announcement. 5. Abbott's stock rose 0.9% to $130.81 after earnings report.